Sponsor or institution

Clinical trials and research at BlueRock Therapeutics

• 2Clinical trials
• 3Countries

All recruiting trials (2)

• Bemdaneprocel for motor symptoms in adults with Parkinson's disease

  This Phase 3 study will test whether bemdaneprocel, a dopaminergic cell therapy, can improve motor symptoms in adults aged 45–75 with Parkinson's disease compared with sham surgery.

  Recruiting at 43 sites Phase 3 BlueRock Therapeutics · Scottsdale, Arizona and 42 other locations · NCT06944522

• Investigating OpCT-001 for treating primary photoreceptor disease

  This study is testing a new treatment called OpCT-001 to see if it can safely help adults with primary photoreceptor diseases, like Retinitis Pigmentosa and Usher Syndrome, improve their vision.

  Recruiting at 5 sites Phase 1/2 BlueRock Therapeutics · Los Angeles, California and 4 other locations · NCT06789445

Quick answers

How many clinical trials run by BlueRock Therapeutics are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United States (2 trials), Australia (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →